Review Article

CXCR2 in Acute Lung Injury

Table 2

Pharmacological approaches on CXCR2 in animals.

Intervention Model Results Reference

Blocking CXCR2 by a self-made antagonist* Lung transplant ischemia-reperfusion injury in rats(i) Marked reduction of neutrophils into the lung
(ii) Attenuated graft injury
[18]
Blocking CXCR2 by a self-made antagonist* Ventilator-induced ALI in mice (i) Reduced PMN sequestration and ALI [17]
Reparixin LPS-/acid-induced ALI in mice(i) Modulation of PMN trafficking
(ii) Reduced vascular permeability
(iii) Improved gas exchange
[34]
Reparixin Reperfusion injury in rats and human/rodent PMNs(i) Effective inhibitor of PMN recruitment
(ii) Attenuated reperfusion injury
[35]
Reparixin Cerebral ischemia in rats(i) Anti-inflammatory and neuroprotective effects
(ii) Inhibition of PMN infiltration
(iii) Reduced tissue damage
[36]
Reparixin Intestinal ischemia and reperfusion injury in rats(i) Reduced neutrophil influx
(ii) Reduced microvascular permeability in lungs and intestines
(iii) Reduced TNFα
(iv) Reduced lethality
[37]
DF2162 Bleomycin-induced pulmonary inflammation and fibrosis in mice(i) Improvement of lung pathology
(ii) Reduced collagen deposition
(iii) Reduced airway PMN migration
(iv) Increased PMN in lung parenchyma
[26]
SCH-N Cigarette smoke-induced lung inflammation in mice(i) Reduced PMNs in BAL
(ii) Reduced perivascular inflammation
(iii) Reduced tissue PMNs
[38]
DF 2156A Human leukocytes, human umbilical vein cells, ischemia/reperfusion injury in rats(i) Decreased monocyte and PMN infiltration
(ii) Reduced TNFα
(iii) Attenuated proliferation, migration and capillary-like organization of human umbilical vein endothelial cells
[39]
DF2156AIschemia/reperfusion injury in rats(i) Decrease of PMN infiltration
(ii) Reduced infarct size
(iii) Improved neurological function
[40]
K11R/G31P Aspiration pneumonia in pigs(i) Attenuated neutrophil response
(ii) Reduced pathology
(iii) Still efficient pulmonary bacterial clearance
[41]
K11R/G31P LPS-induced lung inflammation in pigs(i) Decreased PMN migration into the lung
(ii) Reduced TNFα andl IL-1 levels in the BAL
[42]
K11R/G31PRadiation-induced lung injury in mice(i) Reduced alveolitis but not fibrosis[28]
Sch527123*Intranasal/intratracheal LPS-administration in mice, and rats, repeated bronchoscopy and lavage in cynomolgus monkey(i) Suppressed pulmonary neutrophilia
(ii) Reduced goblet cell hyperplasia
[43]
Simvastatin Streptococcal-induced ALI in mice(i) Reduced infiltration of neutrophils and edema in the lung [44]

*Selective for CXCR2; the other pharmacologic agents also inhibit CXCR1.